The Race to the Bottom Line - Research Report on Endo Health Solutions Inc., Warner Chilcott Public Limited Company, The Gap,

 The Race to the Bottom Line - Research Report on Endo Health Solutions Inc.,
 Warner Chilcott Public Limited Company, The Gap, Inc., Guess?, Inc. and Alto
                                Networks, Inc.

PR Newswire

NEW YORK, February 20, 2013

NEW YORK, February 20, 2013 /PRNewswire/ --

Today, National Traders Association announced new research reports
highlighting Endo Health Solutions Inc. (NASDAQ: ENDP), Warner Chilcott Public
Limited Company (NASDAQ: WCRX), The Gap, Inc. (NYSE:GPS), Guess? Inc.
(NYSE:GES) and Alto Networks, Inc. (NYSE: PANW). Today's readers may access
these reports free of charge - including full price targets, industry analysis
and analyst ratings - via the links below.

ENDO HEALTH SOLUTIONS INC. Research Report

The patents Lidoderm patch and Opana ER tablets are due to expire. Lidoderm
had sales of $825 million in 2011 and this accounted for 30 percent of the
company's revenues. Furthermore, with more deaths arising from painkiller
overdose, regulators have been looking more closely on how painkiller
manufacturers have been handling their products. The company is setting aside
$194 million to cover possible penalties because of a federal investigation
into how the company promoted and sold its Lidoderm patch painkilling drug.
But if ever Endo Health Solutions pushes through with the talks that it will
be put on sale, it could present new opportunities for its company as well as
its potential buyer, Warner Chilcott. Warner Chilcott, being a Canadian
company, will benefit from better tax rates. This would create a stronger cash
flow and increase the value of both companies. The Full Research Report on
Endo Health Solutions Inc. - including full detailed breakdown, analyst
ratings and price targets - is available to download free of charge at:
[http://www.nationaltradersassociation.org/r/entire_report/e000_ENDP]

--

WARNER CHILCOTT PUBLIC LIMITED COMPANY Research Report

After separating from Warner-Lambert in 1996, Warner Chilcott has evolved to
become a fully integrated pharmaceutical company with a broad portfolio of
leading branded products. However, Wall Street has not been kind to Warner
Chilcott in the past year. It had put itself on sale early in 2012, much to
investors' delight, but dropped the sale in August. To make matters more
difficult, Warner Chilcott's acne treatment drug Doryx is facing generic
competition, while Enablex and oral contraceptive Loestrin could both lose
their patents by 2015. Nevertheless, Warner Chilcott CFO Paul Herenden
comments that the company still has strong strategies for its key franchises.
Herendeen asserted that the company is working on improved versions of its
existing products and are developing new products such as a Phase 2 product
for rosacea and acne, and a Phase 3 treatment for erectile dysfunction. The
same threat of generic competition exists for Endo. The patents Lidoderm patch
and Opana ER tablets are due to expire. Lidoderm had sales of $825 million in
2011 and this accounted for 30 percent of the company's revenues. The Full
Research Report on Warner Chilcott Public Limited Company - including full
detailed breakdown, analyst ratings and price targets - is available to
download free of charge at:
[http://www.nationaltradersassociation.org/r/entire_report/5d83_WCRX]

--

THE GAP, INC. Research Report

Gap opened its first outlet stores in China in the latter part of 2012, and is
expected to produce tremendous growth like how competitors Abercrombie & Fitch
and high-end retailer Coach have performed in the country with their stores.
In addition, Gap's namesake brand and its higher-priced banana republic brand
would easily expand there with a significant lack of competition. In addition,
Trefis predicts that the company's European and Japanese sales could improve
this year, as the European Commission expects a gradual improvement in the
region's economy this year until 2014, while the launch of e-commerce will
help improve sales from the still-recovering Japan.A report from India Times
indicates that Gap is set to open up stores in the Indian subcontinent soon,
as rival retailers H&M and Zara also penetrate the potentially lucrative
market. The country's middle class has been growing steadily for being a
popular outsourcing destination for more than a decade now. The Full Research
Report on The Gap, Inc. - including full detailed breakdown, analyst ratings
and price targets - is available to download free of charge at:
[http://www.nationaltradersassociation.org/r/entire_report/e8c3_GPS]

--

GUESS?, INC. Research Report

Meanwhile, Guess has seen its Asian business post exponential growth amid a
relatively weak fiscal year. However, its revenues from that market comprise
only about 10 percent of Guess' total revenue of $250 million for the previous
quarter. The growth is driven by its aggressive expansion during fiscal Q3 for
this year, opening 21 stores and 45 concession shops, with an additional 40 in
its planning stages. Guess also partnered with a Chinese licensee, positioning
itself in China to fuel long-term growth.

Its licensing business has also been growing while its competitors are
struggling in that segment, banking on only its strong brand recognition to
maintain its asset-light high-margin segment.

In addition, the retailer is making a big push into Spain, Germany, Northern
Europe, and Russia over the next five years as the EU reports a positive
economic outlook in that period. The move further diversifies the company away
from the US, and is expected to generate more international sales than local.
The Full Research Report on Guess?, Inc. - including full detailed breakdown,
analyst ratings and price targets - is available to download free of charge
at: [http://www.nationaltradersassociation.org/r/entire_report/6949_GES]

--

ALTO NETWORKS, INC. Research Report

On the other hand, Palo Alto Networks closed its fiscal fourth quarter of 2012
by achieving $75.6 million, a significant increase compared with $40.2 million
in the fiscal fourth quarter of 2011. The company also reported $4.6 million
net loss in the fiscal year of 2012, or 18 cents per basic and diluted share,
against its net loss of $6 million, or 40 cents per basic and diluted share,
in the same quarter of 2011. These improvements continue to push the two
companies' present performance in the recent market close as Palo Alto
Networks' shares climbed $1.43 or 2.65%, to $55.36. The Full Research Report
on Alto Networks, Inc. - including full detailed breakdown, analyst ratings
and price targets - is available to download free of charge at:
[http://www.nationaltradersassociation.org/r/entire_report/6bd4_PANW]

--

Consider National Traders Association

Tired of hearing about the latest, greatest trade opportunity... only to
realize that the ship has long sailed? You need a strong, informative
community in your arsenal. Join the group that has been consistently
identifying momentous situations as they develop - long before they become the
next top news on major financial networks.

Contact: Demi Lapierre
Email: press@NationalTradersAssociation.org
Main: +1-(702)-212-4493

SOURCE National Traders Association
 
Press spacebar to pause and continue. Press esc to stop.